Free Trial
NASDAQ:RKDA

Arcadia Biosciences Q2 2026 Earnings Results & Report

Arcadia Biosciences logo
$0.17 +0.00 (+0.06%)
As of 02:22 PM Eastern

Arcadia Biosciences missed analyst expectations on both earnings and revenue in its Q2 2026 results, released August 13, 2026. The company reported EPS of -$2.09 versus the -$0.56 consensus estimate, while revenue of $1.44 million fell short of the $1.90 million estimate by $457.00 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes
Conference Call
4:00 PM ET

Arcadia Biosciences EPS Results

Actual EPS
-$2.09
Consensus EPS
-$0.56
Beat/Miss
Missed by -$1.53
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 8 quarters

Arcadia Biosciences Revenue Results

Actual Revenue
$1.44 million
Expected Revenue
$1.90 million
Beat/Miss
Missed by -$457.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Arcadia Biosciences' Q3 2026 earnings is estimated for Tuesday, November 10, 2026, based on past reporting schedules

Arcadia Biosciences Q2 2026 Earnings FAQ

Arcadia Biosciences (NASDAQ:RKDA) reported earnings of -$2.09 per share for Q2 2026, missing the consensus estimate of -$0.56. The report was announced on Thursday, August 13, 2026.

Arcadia Biosciences reported revenue of $1.44 million for Q2 2026, against a consensus estimate of $1.90 million.

Arcadia Biosciences' next earnings date is estimated for Tuesday, November 10, 2026. MarketBeat tracks confirmed and estimated earnings dates for Arcadia Biosciences on the company's earnings history page.

Arcadia Biosciences Earnings Headlines

RKDA Share News Today
Many investors are about to lose everything
Twenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.tc pixel
See More Arcadia Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email.

About Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA) is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications.

Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients. Arcadia has also pursued additional crop and ingredient technologies addressing areas such as improved nutrition, sustainability and agricultural productivity.

Founded in 2002 and headquartered in Davis, California, Arcadia has historically operated through research, product development, licensing and commercialization activities in the agricultural and food sectors. Its products and technologies have been marketed primarily in the United States, with potential applications for broader food and agricultural markets.

View Arcadia Biosciences Profile